Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1223

1.

STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.

Andersen MN, Etzerodt A, Graversen JH, Holthof LC, Moestrup SK, Hokland M, Møller HJ.

Cancer Immunol Immunother. 2019 Jan 14. doi: 10.1007/s00262-019-02301-3. [Epub ahead of print]

PMID:
30637473
2.

Neurocognitive and neuroanatomical maturation in the clinical high-risk states for psychosis: A pattern recognition study.

Kambeitz-Ilankovic L, Haas SS, Meisenzahl E, Dwyer DB, Weiske J, Peters H, Möller HJ, Falkai P, Koutsouleris N.

Neuroimage Clin. 2018 Dec 3. pii: S2213-1582(18)30372-3. doi: 10.1016/j.nicl.2018.101624. [Epub ahead of print]

3.

WFSBP guidelines on how to grade treatment evidence for clinical guideline development.

Hasan A, Bandelow B, Yatham LN, Berk M, Falkai P, Möller HJ, Kasper S; WFSBP Guideline Task Force Chairs.

World J Biol Psychiatry. 2018 Dec 11:1-28. doi: 10.1080/15622975.2018.1557346. [Epub ahead of print]

PMID:
30526182
4.

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Kazankov K, Jørgensen SMD, Thomsen KL, Møller HJ, Vilstrup H, George J, Schuppan D, Grønbæk H.

Nat Rev Gastroenterol Hepatol. 2018 Nov 27. doi: 10.1038/s41575-018-0082-x. [Epub ahead of print] Review.

PMID:
30482910
5.

Possibilities and limitations of DSM-5 in improving the classification and diagnosis of mental disorders.

Möller HJ.

Psychiatr Pol. 2018 Aug 24;52(4):611-628. doi: 10.12740/PP/91040. Epub 2018 Aug 24. English, Polish.

6.

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH).

Stubbs B, Vancampfort D, Hallgren M, Firth J, Veronese N, Solmi M, Brand S, Cordes J, Malchow B, Gerber M, Schmitt A, Correll CU, De Hert M, Gaughran F, Schneider F, Kinnafick F, Falkai P, Möller HJ, Kahl KG.

Eur Psychiatry. 2018 Oct;54:124-144. doi: 10.1016/j.eurpsy.2018.07.004.

PMID:
30257806
7.

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.

Björklund J, Laursen TL, Sandahl TD, Møller HJ, Vilstrup H, Ott P, Grønbæk H.

Orphanet J Rare Dis. 2018 Sep 21;13(1):169. doi: 10.1186/s13023-018-0910-7.

8.

Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.

Schennach R, Riedel M, Spellmann I, Musil R, Obermeier M, Jäger M, Bottlender R, Schmauss M, Laux G, Möller HJ.

Pharmacopsychiatry. 2018 Sep 20. doi: 10.1055/a-0669-9461. [Epub ahead of print]

PMID:
30235496
9.

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.

Kimer N, Gudmann NS, Pedersen JS, Møller S, Nielsen MJ, Leeming DJ, Karsdal MA, Møller HJ, Bendtsen F, Grønbæk H.

PLoS One. 2018 Sep 5;13(9):e0203200. doi: 10.1371/journal.pone.0203200. eCollection 2018.

10.

Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.

Heftdal LD, Loft AG, Hendricks O, Ashouri Christiansen A, Schiøttz-Christensen B, Arnbak B, Jurik AG, Østgård R, Winding Deleuran B, Møller HJ, Greisen SR.

Scand J Clin Lab Invest. 2018 Sep 4:1-7. doi: 10.1080/00365513.2018.1500704. [Epub ahead of print]

PMID:
30176763
11.

Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease.

Kazankov K, Alisi A, Møller HJ, De Vito R, Rittig S, Mahler B, Nobili V, Grønbæk H.

J Pediatr Gastroenterol Nutr. 2018 Nov;67(5):635-642. doi: 10.1097/MPG.0000000000002111.

PMID:
30074574
12.

Is schizophrenia still one entity with similar symptomatic patterns, neurobiological characteristics, and treatment perspectives?

Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2018 Sep;268(6):525-527. doi: 10.1007/s00406-018-0926-y. No abstract available.

PMID:
30056559
13.

Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.

Lund Laursen T, Brøckner Siggard C, Kazankov K, Damgaard Sandahl T, Møller HJ, Ong A, Douglas MW, George J, Tarp B, Hagelskjaer Kristensen L, Lund Laursen A, Hiramatsu A, Nakahara T, Chayama K, Grønbaek H.

Scand J Gastroenterol. 2018 Aug;53(8):986-993. doi: 10.1080/00365521.2018.1481996. Epub 2018 Jul 10.

PMID:
29987961
14.

Efficacy of extended clinical management, group CBT, and group plus individual CBT for major depression: Results of a two-year follow-up study.

Schaub A, Goldmann U, Mueser TK, Goerigk S, Hautzinger M, Roth E, Charypar M, Engel R, Möller HJ.

J Affect Disord. 2018 Oct 1;238:570-578. doi: 10.1016/j.jad.2018.05.081. Epub 2018 Jun 13.

PMID:
29940521
15.

Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.

Stübner S, Grohmann R, Greil W, Zhang X, Müller-Oerlinghausen B, Bleich S, Rüther E, Möller HJ, Engel R, Falkai P, Toto S, Kasper S, Neyazi A.

Int J Neuropsychopharmacol. 2018 Sep 1;21(9):814-821. doi: 10.1093/ijnp/pyy048.

16.

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis.

Svart M, Rittig N, Møller N, Møller HJ, Gronbaek H.

J Diabetes Investig. 2019 Jan;10(1):67-72. doi: 10.1111/jdi.12869. Epub 2018 Jun 30.

17.

Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in Human Immunodeficiency Virus Infection.

Andersen MN, Hønge BL, Jespersen S, Medina C, da Silva Té D, Laursen A, Wejse C, Erikstrup C, Møller HJ; Bissau HIV Cohort Study Group .

J Infect Dis. 2018 Sep 8;218(8):1291-1295. doi: 10.1093/infdis/jiy318.

PMID:
29800140
18.

Stigma experiences and perceived stigma in patients with first-episode schizophrenia in the course of 1 year after their first in-patient treatment.

Zäske H, Linden M, Degner D, Jockers-Scherübl M, Klingberg S, Klosterkötter J, Maier W, Möller HJ, Sauer H, Schmitt A, Gaebel W.

Eur Arch Psychiatry Clin Neurosci. 2018 Apr 25. doi: 10.1007/s00406-018-0892-4. [Epub ahead of print]

PMID:
29696357
19.

Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.

Musil R, Seemüller F, Meyer S, Spellmann I, Adli M, Bauer M, Kronmüller KT, Brieger P, Laux G, Bender W, Heuser I, Fisher R, Gaebel W, Schennach R, Möller HJ, Riedel M.

Int J Methods Psychiatr Res. 2018 Mar;27(1). doi: 10.1002/mpr.1569. Epub 2017 Jun 14.

PMID:
29498147
20.

QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.

Spellmann I, Reinhard MA, Veverka D, Zill P, Obermeier M, Dehning S, Schennach R, Müller N, Möller HJ, Riedel M, Musil R.

Eur Arch Psychiatry Clin Neurosci. 2018 Jun;268(4):383-390. doi: 10.1007/s00406-018-0880-8. Epub 2018 Feb 10.

PMID:
29429138

Supplemental Content

Loading ...
Support Center